石药集团：上半年净利润25.5亿元 同比减少15.6%

Group 1 - The core viewpoint of the article highlights that Shijiazhuang Pharmaceutical Group (01093.HK) reported a decline in its mid-year performance for 2025, with revenue and net profit both decreasing significantly [1] Group 2 - The company reported a revenue of 13.27 billion RMB for the first half of 2025, representing a year-on-year decrease of 18.5% [1] - The net profit for the same period was 2.55 billion RMB, which is a year-on-year decrease of 15.6% [1]